Factors Associated with Use of Bone Morphogenetic Protein During Pediatric Spinal Fusion Surgery

Background Our goal was to investigate whether the use of recombinant human bone morphogenetic protein (rhBMP, or BMP) during pediatric spinal fusion surgery has been increasing and how patient, surgical, and hospital characteristics influence BMP use. Methods Using the Nationwide Inpatient Sample d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of bone and joint surgery. American volume 2013, Vol.95 (14), p.1265-1270
Hauptverfasser: Jain, Amit, MD, Kebaish, Khaled M., MD, Sponseller, Paul D., MD, Henze, Elaine P., BJ, ELS
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1270
container_issue 14
container_start_page 1265
container_title Journal of bone and joint surgery. American volume
container_volume 95
creator Jain, Amit, MD
Kebaish, Khaled M., MD
Sponseller, Paul D., MD
Henze, Elaine P., BJ, ELS
description Background Our goal was to investigate whether the use of recombinant human bone morphogenetic protein (rhBMP, or BMP) during pediatric spinal fusion surgery has been increasing and how patient, surgical, and hospital characteristics influence BMP use. Methods Using the Nationwide Inpatient Sample database, we identified 4817 children eighteen years old or younger who had undergone spinal fusion surgery with the use of BMP from 2003 through 2009. A multivariate logistic regression model, the Z-test of proportions, and simple linear regression were used for statistical analysis (significance, p < 0.05). Results There was a 3.4-fold increase in BMP use, from 2.7% in 2003 to 9.3% in 2009—an average 16% per year increase (p < 0.01). For each additional year of age, BMP use increased 1.09-fold (odds ratio [OR]: 1.05 to 1.13, p < 0.01). Compared with BMP use for adolescent idiopathic scoliosis, the adjusted odds of BMP use were increased 1.3-fold for congenital scoliosis (OR: 1.02 to 1.76, p = 0.04), 2.8-fold for thoracolumbar fractures (OR: 2.1 to 3.8, p < 0.01), and 5.0-fold for spondylolisthesis (OR: 3.9 to 6.3, p < 0.01). Patients with private insurance were 1.5-fold more likely to receive BMP (OR: 1.2 to 1.9, p < 0.01). Patients in whom autograft bone was used intraoperatively were 0.63-fold less likely to receive BMP (OR: 0.52 to 0.77, p < 0.01). The rate of BMP use was 0.38-fold lower in teaching hospitals (OR: 0.31 to 0.48, p < 0.01) and 1.7-fold higher in hospitals with a large bed capacity (OR: 1.3 to 2.2, p < 0.01). Compared with hospitals located in the Northeast, those in the West had a 1.7-fold increase (OR: 1.3 to 2.4, p < 0.01) and those in the South had a 2.0-fold increase (OR: 1.5 to 2.7, p < 0.01) in the odds of BMP use. Conclusions Use of BMP during pediatric spinal fusion has increased significantly. Patient factors (age, diagnosis, and insurance), surgical factors (autograft use), and hospital factors (teaching status, bed capacity, and location) influenced the variation in BMP use.
doi_str_mv 10.1016/S0021-9355(13)72326-9
format Article
fullrecord <record><control><sourceid>elsevier</sourceid><recordid>TN_cdi_elsevier_clinicalkeyesjournals_1_s2_0_S0021935513723269</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0021935513723269</els_id><sourcerecordid>1_s2_0_S0021935513723269</sourcerecordid><originalsourceid>FETCH-elsevier_clinicalkeyesjournals_1_s2_0_S00219355137232693</originalsourceid><addsrcrecordid>eNqlT8tKA0EQnIOC0fgJQh_1sDqzkwd7EXwtXoTAxvM4TDqbjstM6J5V8vdugvgDnoqqoooqpa6MvjXazO4arUtTVHY6vTb2Zl7aclZUJ2r0J5-pc5Gt1noy0fOR-qh9yIkFHkRSIJ9xBd-UN_AuCGkNjykivCXebVKLETMFWHDKSBGee6bYwgJXQ4wHo9lR9B3UvVCK0PTcIu_H6nTtO8HLX7xQ9_XL8um1wIF8EbILHUUKvvvEPco29TyUiDNOSqfd8c9ht7HHM5X9d8EPqvxcAQ</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Factors Associated with Use of Bone Morphogenetic Protein During Pediatric Spinal Fusion Surgery</title><source>Alma/SFX Local Collection</source><creator>Jain, Amit, MD ; Kebaish, Khaled M., MD ; Sponseller, Paul D., MD ; Henze, Elaine P., BJ, ELS</creator><creatorcontrib>Jain, Amit, MD ; Kebaish, Khaled M., MD ; Sponseller, Paul D., MD ; Henze, Elaine P., BJ, ELS</creatorcontrib><description><![CDATA[Background Our goal was to investigate whether the use of recombinant human bone morphogenetic protein (rhBMP, or BMP) during pediatric spinal fusion surgery has been increasing and how patient, surgical, and hospital characteristics influence BMP use. Methods Using the Nationwide Inpatient Sample database, we identified 4817 children eighteen years old or younger who had undergone spinal fusion surgery with the use of BMP from 2003 through 2009. A multivariate logistic regression model, the Z-test of proportions, and simple linear regression were used for statistical analysis (significance, p < 0.05). Results There was a 3.4-fold increase in BMP use, from 2.7% in 2003 to 9.3% in 2009—an average 16% per year increase (p < 0.01). For each additional year of age, BMP use increased 1.09-fold (odds ratio [OR]: 1.05 to 1.13, p < 0.01). Compared with BMP use for adolescent idiopathic scoliosis, the adjusted odds of BMP use were increased 1.3-fold for congenital scoliosis (OR: 1.02 to 1.76, p = 0.04), 2.8-fold for thoracolumbar fractures (OR: 2.1 to 3.8, p < 0.01), and 5.0-fold for spondylolisthesis (OR: 3.9 to 6.3, p < 0.01). Patients with private insurance were 1.5-fold more likely to receive BMP (OR: 1.2 to 1.9, p < 0.01). Patients in whom autograft bone was used intraoperatively were 0.63-fold less likely to receive BMP (OR: 0.52 to 0.77, p < 0.01). The rate of BMP use was 0.38-fold lower in teaching hospitals (OR: 0.31 to 0.48, p < 0.01) and 1.7-fold higher in hospitals with a large bed capacity (OR: 1.3 to 2.2, p < 0.01). Compared with hospitals located in the Northeast, those in the West had a 1.7-fold increase (OR: 1.3 to 2.4, p < 0.01) and those in the South had a 2.0-fold increase (OR: 1.5 to 2.7, p < 0.01) in the odds of BMP use. Conclusions Use of BMP during pediatric spinal fusion has increased significantly. Patient factors (age, diagnosis, and insurance), surgical factors (autograft use), and hospital factors (teaching status, bed capacity, and location) influenced the variation in BMP use.]]></description><identifier>ISSN: 0021-9355</identifier><identifier>DOI: 10.1016/S0021-9355(13)72326-9</identifier><language>eng</language><subject>Orthopedics</subject><ispartof>Journal of bone and joint surgery. American volume, 2013, Vol.95 (14), p.1265-1270</ispartof><rights>The Journal of Bone and Joint Surgery, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids></links><search><creatorcontrib>Jain, Amit, MD</creatorcontrib><creatorcontrib>Kebaish, Khaled M., MD</creatorcontrib><creatorcontrib>Sponseller, Paul D., MD</creatorcontrib><creatorcontrib>Henze, Elaine P., BJ, ELS</creatorcontrib><title>Factors Associated with Use of Bone Morphogenetic Protein During Pediatric Spinal Fusion Surgery</title><title>Journal of bone and joint surgery. American volume</title><description><![CDATA[Background Our goal was to investigate whether the use of recombinant human bone morphogenetic protein (rhBMP, or BMP) during pediatric spinal fusion surgery has been increasing and how patient, surgical, and hospital characteristics influence BMP use. Methods Using the Nationwide Inpatient Sample database, we identified 4817 children eighteen years old or younger who had undergone spinal fusion surgery with the use of BMP from 2003 through 2009. A multivariate logistic regression model, the Z-test of proportions, and simple linear regression were used for statistical analysis (significance, p < 0.05). Results There was a 3.4-fold increase in BMP use, from 2.7% in 2003 to 9.3% in 2009—an average 16% per year increase (p < 0.01). For each additional year of age, BMP use increased 1.09-fold (odds ratio [OR]: 1.05 to 1.13, p < 0.01). Compared with BMP use for adolescent idiopathic scoliosis, the adjusted odds of BMP use were increased 1.3-fold for congenital scoliosis (OR: 1.02 to 1.76, p = 0.04), 2.8-fold for thoracolumbar fractures (OR: 2.1 to 3.8, p < 0.01), and 5.0-fold for spondylolisthesis (OR: 3.9 to 6.3, p < 0.01). Patients with private insurance were 1.5-fold more likely to receive BMP (OR: 1.2 to 1.9, p < 0.01). Patients in whom autograft bone was used intraoperatively were 0.63-fold less likely to receive BMP (OR: 0.52 to 0.77, p < 0.01). The rate of BMP use was 0.38-fold lower in teaching hospitals (OR: 0.31 to 0.48, p < 0.01) and 1.7-fold higher in hospitals with a large bed capacity (OR: 1.3 to 2.2, p < 0.01). Compared with hospitals located in the Northeast, those in the West had a 1.7-fold increase (OR: 1.3 to 2.4, p < 0.01) and those in the South had a 2.0-fold increase (OR: 1.5 to 2.7, p < 0.01) in the odds of BMP use. Conclusions Use of BMP during pediatric spinal fusion has increased significantly. Patient factors (age, diagnosis, and insurance), surgical factors (autograft use), and hospital factors (teaching status, bed capacity, and location) influenced the variation in BMP use.]]></description><subject>Orthopedics</subject><issn>0021-9355</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqlT8tKA0EQnIOC0fgJQh_1sDqzkwd7EXwtXoTAxvM4TDqbjstM6J5V8vdugvgDnoqqoooqpa6MvjXazO4arUtTVHY6vTb2Zl7aclZUJ2r0J5-pc5Gt1noy0fOR-qh9yIkFHkRSIJ9xBd-UN_AuCGkNjykivCXebVKLETMFWHDKSBGee6bYwgJXQ4wHo9lR9B3UvVCK0PTcIu_H6nTtO8HLX7xQ9_XL8um1wIF8EbILHUUKvvvEPco29TyUiDNOSqfd8c9ht7HHM5X9d8EPqvxcAQ</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Jain, Amit, MD</creator><creator>Kebaish, Khaled M., MD</creator><creator>Sponseller, Paul D., MD</creator><creator>Henze, Elaine P., BJ, ELS</creator><scope/></search><sort><creationdate>2013</creationdate><title>Factors Associated with Use of Bone Morphogenetic Protein During Pediatric Spinal Fusion Surgery</title><author>Jain, Amit, MD ; Kebaish, Khaled M., MD ; Sponseller, Paul D., MD ; Henze, Elaine P., BJ, ELS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-elsevier_clinicalkeyesjournals_1_s2_0_S00219355137232693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Orthopedics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jain, Amit, MD</creatorcontrib><creatorcontrib>Kebaish, Khaled M., MD</creatorcontrib><creatorcontrib>Sponseller, Paul D., MD</creatorcontrib><creatorcontrib>Henze, Elaine P., BJ, ELS</creatorcontrib><jtitle>Journal of bone and joint surgery. American volume</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jain, Amit, MD</au><au>Kebaish, Khaled M., MD</au><au>Sponseller, Paul D., MD</au><au>Henze, Elaine P., BJ, ELS</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors Associated with Use of Bone Morphogenetic Protein During Pediatric Spinal Fusion Surgery</atitle><jtitle>Journal of bone and joint surgery. American volume</jtitle><date>2013</date><risdate>2013</risdate><volume>95</volume><issue>14</issue><spage>1265</spage><epage>1270</epage><pages>1265-1270</pages><issn>0021-9355</issn><abstract><![CDATA[Background Our goal was to investigate whether the use of recombinant human bone morphogenetic protein (rhBMP, or BMP) during pediatric spinal fusion surgery has been increasing and how patient, surgical, and hospital characteristics influence BMP use. Methods Using the Nationwide Inpatient Sample database, we identified 4817 children eighteen years old or younger who had undergone spinal fusion surgery with the use of BMP from 2003 through 2009. A multivariate logistic regression model, the Z-test of proportions, and simple linear regression were used for statistical analysis (significance, p < 0.05). Results There was a 3.4-fold increase in BMP use, from 2.7% in 2003 to 9.3% in 2009—an average 16% per year increase (p < 0.01). For each additional year of age, BMP use increased 1.09-fold (odds ratio [OR]: 1.05 to 1.13, p < 0.01). Compared with BMP use for adolescent idiopathic scoliosis, the adjusted odds of BMP use were increased 1.3-fold for congenital scoliosis (OR: 1.02 to 1.76, p = 0.04), 2.8-fold for thoracolumbar fractures (OR: 2.1 to 3.8, p < 0.01), and 5.0-fold for spondylolisthesis (OR: 3.9 to 6.3, p < 0.01). Patients with private insurance were 1.5-fold more likely to receive BMP (OR: 1.2 to 1.9, p < 0.01). Patients in whom autograft bone was used intraoperatively were 0.63-fold less likely to receive BMP (OR: 0.52 to 0.77, p < 0.01). The rate of BMP use was 0.38-fold lower in teaching hospitals (OR: 0.31 to 0.48, p < 0.01) and 1.7-fold higher in hospitals with a large bed capacity (OR: 1.3 to 2.2, p < 0.01). Compared with hospitals located in the Northeast, those in the West had a 1.7-fold increase (OR: 1.3 to 2.4, p < 0.01) and those in the South had a 2.0-fold increase (OR: 1.5 to 2.7, p < 0.01) in the odds of BMP use. Conclusions Use of BMP during pediatric spinal fusion has increased significantly. Patient factors (age, diagnosis, and insurance), surgical factors (autograft use), and hospital factors (teaching status, bed capacity, and location) influenced the variation in BMP use.]]></abstract><doi>10.1016/S0021-9355(13)72326-9</doi></addata></record>
fulltext fulltext
identifier ISSN: 0021-9355
ispartof Journal of bone and joint surgery. American volume, 2013, Vol.95 (14), p.1265-1270
issn 0021-9355
language eng
recordid cdi_elsevier_clinicalkeyesjournals_1_s2_0_S0021935513723269
source Alma/SFX Local Collection
subjects Orthopedics
title Factors Associated with Use of Bone Morphogenetic Protein During Pediatric Spinal Fusion Surgery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T01%3A58%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20Associated%20with%20Use%20of%20Bone%20Morphogenetic%20Protein%20During%20Pediatric%20Spinal%20Fusion%20Surgery&rft.jtitle=Journal%20of%20bone%20and%20joint%20surgery.%20American%20volume&rft.au=Jain,%20Amit,%20MD&rft.date=2013&rft.volume=95&rft.issue=14&rft.spage=1265&rft.epage=1270&rft.pages=1265-1270&rft.issn=0021-9355&rft_id=info:doi/10.1016/S0021-9355(13)72326-9&rft_dat=%3Celsevier%3E1_s2_0_S0021935513723269%3C/elsevier%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=1_s2_0_S0021935513723269&rfr_iscdi=true